Mani, V.; Rabbani, S.I.; Shariq, A.; Amirthalingam, P.; Arfeen, M.
Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats. Pharmaceuticals 2022, 15, 1563.
https://doi.org/10.3390/ph15121563
AMA Style
Mani V, Rabbani SI, Shariq A, Amirthalingam P, Arfeen M.
Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats. Pharmaceuticals. 2022; 15(12):1563.
https://doi.org/10.3390/ph15121563
Chicago/Turabian Style
Mani, Vasudevan, Syed Imam Rabbani, Ali Shariq, Palanisamy Amirthalingam, and Minhajul Arfeen.
2022. "Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats" Pharmaceuticals 15, no. 12: 1563.
https://doi.org/10.3390/ph15121563
APA Style
Mani, V., Rabbani, S. I., Shariq, A., Amirthalingam, P., & Arfeen, M.
(2022). Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats. Pharmaceuticals, 15(12), 1563.
https://doi.org/10.3390/ph15121563